Literature DB >> 11141203

Determining the optimal pacing intervention rate for vasovagal syncope.

A S Kurbaan1, A C Franzén, Z Stack, D Heaven, G Mathur, R Sutton.   

Abstract

INTRODUCTION: In this study, patients with rate hysteresis pacemakers implanted for vasovagal syncope were re-studied using serial tilt testing to determine whether, once triggered, pacing was more effective if the intervention rate was higher than the standard rate. METHODS AND
RESULTS: Twenty patients (mean age 55.4 years, range 23-81, 14 male) were studied, with randomisation to either initial standard rate (80-90 beats/min) intervention, or to initial high rate (120 beats/min) intervention. Although 18 of the 20 reported complete abolition of syncope since pacing, only 8 patients could be objectively assessed. The respective mean time to tilt down after symptom onset with standard and high rate intervention was 193+/-234s and 185+/-143s, (P>0.05).
CONCLUSION: Repeat tilt testing was only of limited value in assessing the benefit of pacing. There was no advantage with high rate intervention in delaying the loss of consciousness (or intolerable symptoms) after the initial onset of symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 11141203     DOI: 10.1023/a:1026509430078

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  13 in total

1.  Recommendations for pacemaker prescription for symptomatic bradycardia. Report of a working party of the British Pacing and Electrophysiology Group.

Authors: 
Journal:  Br Heart J       Date:  1991-08

2.  ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

Authors:  G Gregoratos; M D Cheitlin; A Conill; A E Epstein; C Fellows; T B Ferguson; R A Freedman; M A Hlatky; G V Naccarelli; S Saksena; R C Schlant; M J Silka
Journal:  Circulation       Date:  1998-04-07       Impact factor: 29.690

3.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.

Authors:  S J Connolly; R Sheldon; R S Roberts; M Gent
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

4.  "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.

Authors:  D G Benditt; R Sutton; M Gammage; T Markowitz; J Gorski; G Nygaard; J Fetter
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

5.  A comparison of non-invasive continuous finger blood pressure measurement (Finapres) with intra-arterial pressure during prolonged head-up tilt.

Authors:  M E Petersen; T R Williams; R Sutton
Journal:  Eur Heart J       Date:  1995-11       Impact factor: 29.983

6.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

7.  Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degrees tilt.

Authors:  A Fitzpatrick; G Theodorakis; R Ahmed; T Williams; R Sutton
Journal:  Pacing Clin Electrophysiol       Date:  1991-01       Impact factor: 1.976

8.  Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease.

Authors:  X C Chen; M Y Chen; S Remole; Y Kobayashi; A Dunnigan; S Milstein; D G Benditt
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

9.  Methodology of head-up tilt testing in patients with unexplained syncope.

Authors:  A P Fitzpatrick; G Theodorakis; P Vardas; R Sutton
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

10.  Permanent pacing for cardioinhibitory malignant vasovagal syndrome.

Authors:  M E Petersen; R Chamberlain-Webber; A P Fitzpatrick; A Ingram; T Williams; R Sutton
Journal:  Br Heart J       Date:  1994-03
View more
  4 in total

Review 1.  Has cardiac pacing a role in vasovagal syncope?

Authors:  Richard Sutton
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 2.  Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials-Precise patient selection and measurable benefit.

Authors:  Richard Sutton; Jelle S Y de Jong; Julian M Stewart; Artur Fedorowski; Frederik J de Lange
Journal:  Heart Rhythm       Date:  2020-02-06       Impact factor: 6.343

3.  Pacing for vasovagal syncope.

Authors:  Nevin T Wijesekera; Arvinder S Kurbaan
Journal:  Indian Pacing Electrophysiol J       Date:  2002-10-01

4.  Tilt testing remains a valuable asset.

Authors:  Richard Sutton; Artur Fedorowski; Brian Olshansky; J Gert van Dijk; Haruhiko Abe; Michele Brignole; Frederik de Lange; Rose Anne Kenny; Phang Boon Lim; Angel Moya; Stuart D Rosen; Vincenzo Russo; Julian M Stewart; Roland D Thijs; David G Benditt
Journal:  Eur Heart J       Date:  2021-05-01       Impact factor: 35.855

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.